The Kaposi sarcoma-associated herpes virus (KSHV) was discovered in 1994 and is associated with Kaposi’s sarcoma as well as B-cell cancers.

Kaposi’s sarcoma first appeared in the medical lexicon in 1872, when Moritz Kaposi noticed skin lesions occurring in elderly men in Vienna. The men were likely infected with KSHV as children, and ...

The approval for Kaposi sarcoma was based on an open-label, single-arm study that evaluated the safety and efficacy of pomalidomide in 28 patients (18 HIV-positive, 10 HIV-negative).

Kaposi sarcoma is a slow-growing vascular tumor localized to skin, but which spreads to internal viscera in 40% of immunosuppressed post-transplant patients. Kaposi sarcoma results from either primary ...

Antibody titres against Kaposi's sarcoma associated herpesvirus (KSHV or human herpesvirus 8 (HHV-8)) and Epstein–Barr virus (EBV) were examined in people who subsequently developed Kaposi's ...

KAPOSI'S sarcoma, or "idiopathic multiple hemorrhagic sarcoma," was first described as a clinical entity by Kaposi in 1872. The disease is progressive, and it exhibits a wide range of clinical and ...

The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a recent study, 86% of participants had advanced Kaposi’s sarcoma and more than 25% ...

The Kaposi sarcoma-associated herpes virus (KSHV) was discovered in 1994 and is associated with Kaposi's sarcoma as well as B-cell cancers. KSHV-associated diseases affect internal organs and are ...

The Breakthrough Therapy designation was based on data from a clinical study involving 22 patients with Kaposi sarcoma. Results showed that among these patients, Pomalyst was well tolerated and ...

The complete Kaposi sarcoma-associated herpesvirus genome induces early-onset, metastatic angiosarcoma in transgenic mice. Cell Host & Microbe, 2024; DOI: 10.1016/j.chom.2024.03.012 ...

Nonepidemic Kaposi sarcoma (KS) in men who have sex with men who are not living with HIV and have no other known causes for immunodeficiency, an emerging fifth subtype of KS, has been ...

Freeman, E.E., et al. (2022) Evaluation of four chemotherapy regimens for treatment of advanced AIDS-associated Kaposi sarcoma in Kenya: a cost-effectiveness analysis.